Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Orphina Biotechnology Logo
Orphina Biotechnology CB Rank
2548154
Heat Score
43
Orphina is a biotechnology company that develops muscle function.
Founded
obfuscation
Private Calabasas, California, United States1-10 orphina.com
Biotechnology
Clinical Trials
Genetics
Overview

Orphina Biotechnology
Heat Score
43

Growth Score
pts
in past quarter
Heat Score 43
20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Orphina Biotechnology

CB Rank
2548154
Orphina is a biotechnology company that develops muscle function.
Founded
obfuscation
Private Calabasas, California, United States1-10 orphina.com
Biotechnology
Clinical Trials
Genetics

Details

Legal Name Orphina Biotechnology
Operating Status Active
Company Type For Profit
Phone Number +1 805 222 4771
Contact Email info@orphina.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

H001 Gene Therapy for GNEM
A non-viral gene therapy designed to increase sialic acid production in distal limb muscles for patients with GNE Myopathy, allowing re-dosing while protecting vital organs.
H001n Gene Therapy for GNEM
A next-generation non-viral gene therapy for GNEM that builds on H001 with improved therapeutic gene expression.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News
Technology
View Tech Report

IT Spend

$133.1KThis year, Orphina Biotechnology is projected to spend $133.1K on IT, according to Aberdeen.

Active Website Tech Count

9Orphina Biotechnology is actively using 9 technologies for its website, according to BuiltWith. These include Euro, Content Delivery Network, and  jsDelivr.

Total IP

1Orphina Biotechnology has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Orphina Biotechnology's headquarters? Orphina Biotechnology is located in Calabasas, California, United States.Who are Orphina Biotechnology's competitors? Alternatives and possible competitors to Orphina Biotechnology may include Sarepta Therapeutics, Dyne Therapeutics, and  CANbridge Pharmaceuticals.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8b214dc 1)
|